LB-456640-4 NONINVASIVE VAGUS NERVE STIMULATION IN POSTURAL TACHYCARDIA SYNDROME: A RANDOMIZED CLINICAL TRIAL

Noninvasive Vagus Nerve Stimulation for Migraine

“We assessed whether longer treatment duration was associated with clinically meaningful results, as previously reported in a study of neuromodulation in chronic migraine,” wrote researcher Stephen D. Silberstein, MD, of Jefferson Headache Center, Philadelphia, and colleagues in Neurology. “Participants originally randomized to nVNS and who continued open-label treatment for 6 months had a sign...

Vagus nerve stimulation: Invasive or noninvasive?

Clinical Policy Title: Vagus nerve stimulation (VNS)

ABOUT THIS POLICY: AmeriHealth Caritas Louisiana has developed clinical policies to assist with making coverage determinations. AmeriHealth Caritas Louisiana’s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional so...

Chronic migraine headache prevention with noninvasive vagus nerve stimulation

OBJECTIVE To evaluate the feasibility, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS) for the prevention of chronic migraine (CM) attacks. METHODS In this first prospective, multicenter, double-blind, sham-controlled pilot study of nVNS in CM prophylaxis, adults with CM (≥15 headache d/mo) entered the baseline phase (1 month) and were subsequently randomized to nVNS or...

Clinical Policy Bulletin: Vagus Nerve Stimulation

Aetna considers vagus nerve electrical stimulators medically necessary durable medical equipment (DME) for shortening the duration or reducing the severity of seizures in members with partial onset seizures who remain refractory to optimal anti-epileptic medications and/or surgical intervention, or who have debilitating side effects from anti-epileptic medications. (Note: Electronic analysis of...